Roche has received FDA clearance for its Accu-Chek Nano SmartView system for monitoring blood glucose. The device, which is targeted for U.S. market launch in the first half of this year, is designed to allow diabetes patients to create personalized test alerts and meal markers, as well as compute their average glucose levels.
Blood glucose monitor from Roche gets FDA OK
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||